Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "sanofi country"

French dengue vaccine backed by data analysis
CTV News

Sanofi preps for 'profitable' dengue vaccine rollout in 20 cou...

With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only ... FiercePharma, 1 week ago
Data analyses back Sanofi dengue vaccine: study Yahoo! India, 15 hours ago

New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protect

s Pre-Adolescents to Adults Against Dengue - The highest burden of dengue disease globally in endemic countries is in pre- adolescent to adults age group[1],[2],[3] - * In a new pooled analysis, dengue vaccine candidate protected two out of ...
 Quoteline21 hours ago Dengue vaccine protects people nine years or older — but harms younger kids  The Verge18 hours ago Sanofi Pasteur's vaccine candidate protects pre-adolescents to adults against dengue  Financial Express4 hours ago REG-New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue  Reuters21 hours ago

Sanofi paying up to $300M for rare thyroid cancer drug

AstraZeneca said it had $48 million in sales of Caprelsa in 2014. The drug is on the market in 28 countries, including the U.S., as a treatment for inoperable medullary thyroid cancer, a disease that attacks thyroid cells that maintain calcium ...
 Investor's Business Daily19 hours ago Sanofi says it will pay up to $300M for AstraZeneca's rare thyroid cancer treatment Caprelsa  FOXBusiness.com19 hours ago

Sanofi says new data analyses support its dengue vaccine

Reuters 1 minute 1 second ago PARIS (Reuters) - French drugmaker Sanofi said on Monday that new data analyses published in the New England Journal of Medicine confirmed that its vaccine candidate against dengue protected two-thirds of the ...
 Yahoo! India21 hours ago

AstraZeneca sells Caprelsa to Sanofi for up $300M

s Editor Boosting its rare disease medicine offerings, Sanofi (NYSE:SNY) has agreed to buy cancer drug Caprelsa from AstraZeneca (NYSE:AZN) for as much as $300M, including an upfront payment of $165M and sales milestone payments of up to $135M. ...
 Seeking Alpha1 day ago

Awareness about influenza

Actor-filmmaker Farhan Akhtar, also a father of two, has been roped in as the cause ambassador of Sanofi Pasteur India's flu awareness campaign. The Rock On!! star will spread awareness about influenza prevention through vaccination. The campaign is an ...
 Deccan Herald1 week ago Actor-Filmmaker Farhan Akhtar to Spread Awareness About Influenza Prevention  MedIndia1 week ago

AstraZeneca in $300m deal to sell cancer drug

ASTRAZENECA , under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi as it continues a drive to raise cash by divesting certain assets. Sanofi's rare diseases division Genzyme will pay ...
 4 Traders8 hours ago Genzyme to Buy Caprelsa from AstraZeneca...  Genetic Engineering News11 hours ago Genzyme Acquires Caprelsa from AstraZeneca  Citybizlist13 hours ago AstraZeneca snags $300M from Sanofi for rare cancer med amid cash-generating deal spree  FiercePharma21 hours ago

Sanofi Pasteur drafts Bollywood star to talk up flu shots in India

Farhan Akhtar For celebrity campaigns in the U.S., pharma often goes to Hollywood. In India, it's Bollywood--and Sanofi Pasteur is doing just that. The Sanofi ( $SNY ) vaccines venture tapped popular actor and director Farhan Akhtar to launch ...
 FiercePharmaMarketing5 days ago Sanofi Pasteur to educate parents in India to prevent seasonal influenza  PharmaBiz1 week ago

Sanofi Russia unveils plans to export medicines to Europe

French Sanofi, a leading player on the Russian pharmaceutical market, will export medicines from Russia to Germany starting Q1 2016, the company announced today. Specifically, it will export insulin produced at Sanofi-Aventis Vostok plant in the ...
 Individual.com1 week ago

Sanofi (SNY) Jumps Into a $2.2 Billion Cancer Deal With Long-Time Partner Regeneron (REGN) 7/28/2015

- Companies agree to jointly advance PD-1 and other new immuno-oncology antibodies Sanofi commits to an initial investment of up to $2.17 billion in the exclusive collaboration, including $640 million in upfront payments to Regeneron and a ...
 ClinicSpace1 hour ago Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients  News-Medical.Net5 hours ago Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration  Ulitzer8 hours ago Sanofi Jumps Into a $2.2 Billion Cancer Deal With Long-Time Partner Regeneron  BioSpace55 minutes ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less